Osteoarthritis: the risk anti-inflammatory medications pose
An Australian study in the prestigious BMJ published on 31/3/2015 provides new evidence that paracetamol is no better than placebo for lower back pain and its effect on osteoarthritis (OA) of the hip or knee is too small to be clinically worthwhile, despite being recommended as the first line drug treatment for both conditions. In their 2017
